CDIA
AMGN icon

Capital Directions Investment Advisors’s Amgen AMGN Stock Holding History

Capital Directions Investment Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-250
Closed -$46K – 147
2018
Q2 		$46K Buy
+250
New +$44.2K 0.02% 75

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Directions Investment Advisors's AMGN Position: Q3 2018 in Review

Capital Directions Investment Advisors sold out of Amgen (AMGN) in Q3 2018, closing a stake of 250 shares — an estimated $46K sold.

Capital Directions Investment Advisors first reported a position in AMGN in Q2 2018 and held it in 1 quarter. The position peaked at $46K in Q2 2018. 1,796 funds tracked by Wall St. Rank hold AMGN as of Q3 2018.

  • Capital Directions Investment Advisors reported no remaining Amgen position as of Q3 2018 after selling out during the quarter.
  • Capital Directions Investment Advisors sold 250 Amgen shares in Q3 2018, an estimated $46K.
  • Capital Directions Investment Advisors first reported a position in Amgen in Q2 2018 and held it in 1 quarter.
  • Capital Directions Investment Advisors's Amgen position peaked at $46K in Q2 2018.
  • 1,796 funds tracked by Wall St. Rank held Amgen as of Q3 2018.

Based on Capital Directions Investment Advisors's 13F filing for Q3 2018, filed 14 Nov 2018.